IonQ, Inc. filings document a public quantum technology company with common stock, warrants and recurring capital-structure disclosures. Its 8-K reports include operating and financial results, material-event updates, registration rights agreements, unregistered equity issuances, resale prospectus supplements and acquisition-related share issuances, including the completed Skyloom Global acquisition.
IonQ proxy materials cover shareholder voting matters, board governance, executive compensation and pay-versus-performance disclosures. The company’s filing record also reflects material agreements, warrant and common-stock terms, financial reporting furnished with earnings releases, and governance matters connected to its quantum computing, networking, sensing, security and space-based data businesses.
A shareholder of IONQ filed a Form 144 notice covering a planned sale of 25,000 common shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $1,216,250. The filing notes that there were 354,279,591 common shares outstanding as of the time referenced. The shares to be sold stem from 25,000 restricted stock units acquired on 09/10/2024 from the issuer.
The seller, identified in the past‑sales section as Rima Alameddine, reports additional common share sales in the prior three months under a Rule 10b5‑1 trading plan, including 25,000 shares on 11/28/2025 for $1,241,500.00, 100,000 shares on 11/20/2025 for $4,689,060.00, and 19,976 shares on 09/11/2025 for $886,966.36. The new 25,000‑share sale is expected around 12/04/2025.
IonQ Inc. has a shareholder filing a notice under Rule 144 to sell 1,400,000 shares of its common stock through Merrill Lynch on the NYSE, with an aggregate market value of $65,098,758.20 as of the notice. The filing notes that 354,279,591 shares of common stock were outstanding. The 1,400,000 shares to be sold were acquired on 02/09/2021 via a stock option transaction from Thomas Kramer, with payment also made on that date through the stock option.
IonQ, Inc. insider Rima Alameddine has filed a Form 144 notice to sell 25,000 shares of IonQ common stock through Morgan Stanley Smith Barney LLC on the NYSE around 11/28/2025, with an aggregate market value of 1,172,500.00. IonQ had 354,279,591 shares of common stock outstanding.
The 25,000 shares to be sold were acquired on 12/10/2023 as restricted stock units from the issuer. Over the prior three months, the seller completed additional common stock sales, including 100,000 shares on 11/20/2025 for gross proceeds of 4,689,060.00 and 19,976 shares on 09/11/2025 for gross proceeds of 886,966.36, identified as 10b5-1 sales for Rima Alameddine.
IonQ, Inc. (IONQ) reported an insider stock sale by one of its officers, who serves as Chief Revenue Officer. On 11/20/2025, the reporting person sold 100,000 shares of IonQ common stock in an open market transaction at a weighted average price of $46.8906 per share. After this transaction, the officer beneficially owned 432,616 shares, held directly.
The filing notes that the trades were carried out under a pre-arranged Rule 10b5-1 trading plan that was adopted on March 14, 2025 and amended on August 21, 2025. The shares were sold in multiple trades at prices ranging from $43.59 to $49.41, and the reporting person has agreed to provide detailed price breakdowns upon request.
IonQ, Inc. reported that Chief Revenue Officer Rima Alameddine will leave the company, with her last day as an employee on November 24, 2025. Under IonQ’s Amended and Restated Executive Severance Plan and her PSU award agreement, she will receive cash severance equal to nine months of base salary, 100% of her 2025 target bonus, and a pro-rated portion of her 2025 bonus paid over nine months.
The company will pay COBRA health premiums for up to nine months after her coverage ends on November 30, 2025, and all unvested restricted stock units and options will fully vest, with PSUs vesting at target on a pro-rated basis. Ms. Alameddine will serve as a non-employee advisor from November 24 through December 31, 2025 at her current base salary. IonQ also announced, via a press release filed as an exhibit, the appointment of Scott Millard as Chief Business Officer.
IONQ insider plans to sell common stock under Rule 144. A holder has filed a notice to sell 100,000 shares of IONQ common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $4,788,000 based on the pricing used in the notice. The filing states that 354,279,591 shares of IONQ common stock were outstanding at the time referenced. The securities were acquired as restricted stock units from the issuer on December 10, 2023, and fully vested on that date for this amount. Over the past three months, the same seller disposed of 19,976 common shares for gross proceeds of $886,966.36. By signing the notice, the seller represents that they are not aware of any material adverse, nonpublic information about IONQ’s operations.
IonQ, Inc. (IONQ) reported a new equity grant to one of its directors, who also serves as a special advisor. On 11/17/2025, the reporting person received 83,700 shares of common stock as a restricted stock unit (RSU) award at a stated price of $0 per share. Following this grant, the reporting person beneficially owns 86,763 shares of IonQ common stock in total.
The RSUs will vest over four years, with 1/16 of the award vesting quarterly on each March 10, June 10, September 10, and December 10, as long as the individual continues as a service provider through each vesting date. This filing is reported as a Form 4 for a single reporting person and reflects non-derivative stock ownership only, with no derivative securities reported.
IonQ (IONQ) reported an insider share purchase. A company director bought 2,000 shares of common stock on 11/11/2025 at a price of $54.815 per share. Following the transaction, the director beneficially owns 6,413 shares, held directly. The filing lists the transaction code as “P,” indicating an open‑market or private purchase.
IonQ, Inc. (IONQ) reported an insider equity grant. The company’s CFO & COO received 274,947 restricted stock units (RSUs) on 11/10/2025 at a stated price of $0. The RSUs vest in full on September 10, 2027, subject to continued service. Following this award, the officer beneficially owns 440,754 shares, reported as direct ownership.
IonQ, Inc. filed a prospectus supplement covering the resale of 2,108,993 shares of its common stock. The resale is by a selling stockholder under the company’s automatic shelf registration (Form S-3ASR, File No. 333-285279).
The filing was made pursuant to a Registration Rights Agreement with The University of Chicago, entered into on November 7, 2025 and effective as of November 10, 2025. IonQ also filed a legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP as an exhibit.
This is an administrative step to register shares for potential resale by the holder; it does not, by itself, change IonQ’s operations or disclose new financial results.